| Date Filed | Type | Description |
| 10/11/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 10/02/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/29/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 09/27/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
| 08/24/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 7.9% stake in Gamida Cell Ltd. |
| 08/21/2023 |
SC 13D
| Community US Fund Management, Inc. reports a 5% stake in Gamida Cell Ltd. |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/14/2023 |
8-K
| Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Departure of Directors or Certain ... |
| 05/26/2023 |
SC 13D/A
| NOVARTIS PHARMA AG reports a 4.1% stake in Gamida Cell Ltd. |
| 05/19/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/09/2023 |
DEFR14A
| Form DEFR14A - Revised definitive proxy soliciting materials: |
| 04/25/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/24/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/21/2023 |
8-K
| Quarterly results |
| 04/20/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 04/20/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/19/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 04/17/2023 |
8-K
| Quarterly results |
| 04/04/2023 |
SC 13D/A
| AI Gamida Holdings LLC reports a 12% stake in Gamida Cell Ltd. |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/27/2023 |
8-K
| Results of Operations and Financial Condition, Cost Associated with Exit or Disposal Activities, Financial Statements and Exh... |
| 03/20/2023 |
8-K
| Quarterly results |
| 02/14/2023 |
SC 13G
| Community US Fund Management, Inc. reports a 6.8% stake in Gamida Cell Ltd. |
| 02/10/2023 |
SC 13G/A
| HIGHBRIDGE CAPITAL MANAGEMENT LLC reports a 5.4% stake in Gamida Cell Ltd. |
| 02/09/2023 |
SC 13G/A
| FMR LLC reports a 9.3% stake in GAMIDA CELL LTD |
| 01/30/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 01/30/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 01/23/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/20/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 01/19/2023 |
8-K
| Quarterly results |
| 01/11/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 01/10/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 01/09/2023 |
8-K
| Quarterly results |
|